Pura Vida Investments’s 89bio ETNB Stock Holding History

Pura Vida Investments’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-50,000	Closed	-$637K	–	112
2022 Q4	$637K	Buy	+50,000	New	+$450K	0.03%	160

Other funds holding ETNB

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Pura Vida Investments's ETNB Position: Q1 2023 in Review

Pura Vida Investments sold out of 89bio (ETNB) in Q1 2023, closing a stake of 50,000 shares — an estimated $637K sold.

Pura Vida Investments first reported a position in ETNB in Q4 2022 and held it in 1 quarter. The position peaked at $637K in Q4 2022. 145 funds tracked by Wall St. Rank hold ETNB as of Q1 2023.

Pura Vida Investments reported no remaining 89bio position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 50,000 89bio shares in Q1 2023, an estimated $637K.
Pura Vida Investments first reported a position in 89bio in Q4 2022 and held it in 1 quarter.
Pura Vida Investments's 89bio position peaked at $637K in Q4 2022.
145 funds tracked by Wall St. Rank held 89bio as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.